To fight off viral and bacterial invaders, immune cells known as lymphocytes generate antibodies that specifically recognize ...

The antibody-drug conjugate is approved for previously treated advanced NSCLC patients with high c-Met protein overexpression ...

Tumor staging was reconfirmed according to the 8th Edition of the American Joint Committee on Cancer (AJCC) TNM Classification for Lung Cancer (18 ... patients were adenocarcinoma (n=61), squamous ...

In this review, we synthesize current knowledge about the tuft cell-ILC2 circuit in intestinal type 2 mucosal immunity, highlight recent mechanistic discoveries, and discuss its implications for host ...

In announcing (Chinese) ivonescimab’s Chinese approval in first-line PD-L1-positive non-small cell lung cancer on Friday, Akeso noted that the bispecific drug slashed the risk of death by 22.3% ...

“The most fundamental things you can ask of a bacterium: How does it grow and divide? How does it control its cell cycle? Those are things that we don’t understand for this pathogen,” Aldridge said.

A rare cell type in the lungs is essential to survival ... may keep the human immune system's initial counterattack on the virus (lung inflammation) from spiraling out of control to endanger ...

A rare lung cell helps stop COVID-19 from becoming deadly by calming the immune system’s overreaction, not by attacking the virus. This discovery could change how we treat respiratory diseases. Credit ...

The U.S. is an outlier in recommending annual COVID-19 vaccination universally to adults without risk factors and to children, noted Shira Doron, MD, MS, of Tufts Medical Center in Boston ...

NICE is unable to make a recommendation on tislelizumab (Tevimbra) in combination for untreated advanced non-small-cell lung cancer in adults. This is because the company did not provide an evidence ...

“Optune Lua is an innovative and urgently needed new approach for treating metastatic non-small cell lung cancer,” said Joachim Aerts, M.D., a LUNAR investigator and Professor of Pulmonary ...

Purdue University scientists have identified the Supinoxin small-molecule drug as a possible new therapy for small-cell lung cancer (SCLC). "Some cancer types are incredibly difficult to treat ...